These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16707384)

  • 1. Acute myeloid leukemia with pseudo-Chèdiak-Higashi anomaly exhibits a specific immunophenotype with CD2 expression.
    Chang H; Yi QL
    Am J Clin Pathol; 2006 May; 125(5):791-4. PubMed ID: 16707384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients.
    Perea G; Domingo A; Villamor N; Palacios C; Juncà J; Torres P; Llorente A; Fernández C; Tormo M; Queipo de Llano MP; Bargay J; Gallart M; Florensa L; Vivancos P; Martí JM; Font L; Berlanga J; Esteve J; Bueno J; Ribera JM; Brunet S; Sierra J; Nomdedéu JF;
    Leuk Res; 2005 Oct; 29(10):1109-16. PubMed ID: 16095690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electron microscopic cytochemistry of pseudo-Chediak-Higashi granules in 5 cases of AML].
    Mizushima W; Eguchi M; Sakakibara H; Sugita K; Furukawa T; Kanagawa M; Suda T; Yoshida M; Miura Y; Matsui J
    Rinsho Ketsueki; 1990 Jun; 31(6):799-806. PubMed ID: 2214171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR antigen-negative acute myeloid leukemia.
    Wetzler M; McElwain BK; Stewart CC; Blumenson L; Mortazavi A; Ford LA; Slack JL; Barcos M; Ferrone S; Baer MR
    Leukemia; 2003 Apr; 17(4):707-15. PubMed ID: 12682628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunophenotypic and cytogenetic characteristics of the blast cells in subvariants of acute myeloid leukemia].
    Isakova LM; Tretiak NN; Khromiak VN; Gordienko AI; Zverkova AS; Vakul'chuk AM
    Tsitol Genet; 2000; 34(1):48-56. PubMed ID: 10808542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudo-Chediak Higashi anomaly in an Indian patient with acute myeloid leukemia (AML-M2).
    Powari M; Varma N; Varma S; Komal HS
    Am J Hematol; 2000 Dec; 65(4):324-5. PubMed ID: 11074565
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
    Al-Mawali A; Gillis D; Hissaria P; Lewis I
    Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudo-Chediak-Higashi anomaly in acute myeloid leukemia (M2) of childhood.
    Aonuma K; Komiyama A; Akabane T
    Acta Paediatr Jpn; 1990 Dec; 32(6):651-5. PubMed ID: 2082666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic quantitative features of patients with acute myeloid leukemia.
    Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
    Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-M0). Evaluation and a proposal.
    Kaleem Z; White G
    Am J Clin Pathol; 2001 Jun; 115(6):876-84. PubMed ID: 11392885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of T-cell markers in acute myeloid leukemia.
    Lewis RE; Cruse JM; Sanders CM; Webb RN; Suggs JL
    Exp Mol Pathol; 2007 Dec; 83(3):462-3. PubMed ID: 17927977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.
    van der Holt B; Van den Heuvel-Eibrink MM; Van Schaik RH; van der Heiden IP; Wiemer EA; Vossebeld PJ; Löwenberg B; Sonneveld P
    Clin Pharmacol Ther; 2006 Nov; 80(5):427-39. PubMed ID: 17112800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.
    Bakker AB; van den Oudenrijn S; Bakker AQ; Feller N; van Meijer M; Bia JA; Jongeneelen MA; Visser TJ; Bijl N; Geuijen CA; Marissen WE; Radosevic K; Throsby M; Schuurhuis GJ; Ossenkoppele GJ; de Kruif J; Goudsmit J; Kruisbeek AM
    Cancer Res; 2004 Nov; 64(22):8443-50. PubMed ID: 15548716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry.
    Zelezníková T; Babusíková O
    Neoplasma; 2005; 52(6):517-22. PubMed ID: 16284699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
    Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The psuedo-Chediak-Higashi anomaly: an unusual staining pattern in an Indian child with acute myeloid leukemia.
    Ahluwalia J; Kumar V; Trehan A; Marwaha RK; Garewal G
    Pediatr Hematol Oncol; 2004; 21(3):199-202. PubMed ID: 15202158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
    Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
    Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T; Babusíková O
    Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.